Markel no longer (as much) on sale

Markel (MKL -0.4%) bulls can fondly recall December 2012, when a dive in the stock following the announcement of the Alterra acquisition allowed them to buy more of this serial compounder at book value.

Amid the integration of Alterra's insurance operations, and its investment portfolio being turned over to CIO Tom Gaynor, Markel is up about 50% since and now trades at 1.3x March 31 book value per share of $493.96 (up 4% from Q4).

Previously: Markel Corp beats by $0.51, beats on revenue

From other sites
Comments (2)
  • murph27
    , contributor
    Comments (4) | Send Message
    Totally agree. Not pricey enough to sell but not enough of a bargain to buy. Very fairly priced right now.
    8 May 2014, 01:47 PM Reply Like
  • User 12154021
    , contributor
    Comments (9) | Send Message
    What happens if they continue to grow BV at 20% per annum? Or even 10%; and your holding period is 5-10 yrs.
    9 May 2014, 11:50 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs